An official website of the United States government

Madagascar Receives More than 100,000 COVID-19 Vaccine Doses through COVAX
Since July 2021, the U.S. government has provided more than 2.2 million doses of safe COVID-19 vaccines
July 8, 2022

ANTANANARIVO – More than 100,000 doses of the safe and effective Pfizer COVID-19 vaccine arrived earlier this week in Madagascar through the COVAX mechanism. Purchased with funding from the U.S. government, these vaccines are part of the Biden Administration’s global effort to increase vaccine coverage. Since July 2021, the United States has provided more than 2.2 million vaccine doses to the people of Madagascar.

“I encourage Malagasy citizens to take advantage of these free, safe, and effective vaccines,” U.S. Ambassador Claire Pierangelo said. “Widespread vaccination is the surest path to recovering from this pandemic, rebuilding our communities, and reinvigorating our economies,” she added.

The U.S. government is working alongside the Government of Madagascar like “mpirahalahy mianala” to ensure that communities across the country have the resources they need to protect themselves, their families, and their communities. For example, the U.S. government, through the U.S. Agency for International Development (USAID), contributed $16.5 million in 2022 alone to support Madagascar’s COVID-19 response. This funding has made possible disease surveillance, disease prevention and control, supply chain management, public awareness campaigns, and vaccinations through USAID ACCESS and IMPACT programs.

The U.S. government will continue to work closely with the Government of Madagascar and governments around the world to protect public health and build a world that is safer and more secure against the threat of COVID-19 and other infectious diseases.

“We have to double down on our efforts […] to get shots in people’s arms, country by country, community by community; ensure we have reliable and predictable supplies of vaccines and boosters for everyone, everywhere; expand access globally to tests and treatments; and we have to prevent complacency” U.S. President Joe Biden said.